batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Mersana’s discontinuation was a long time coming 27 July 2023 How Beigene’s PD-1 just can’t crack the west 18 July 2023 Theseus’s ASCO setback is real 14 July 2023 Merck’s struggles in gastric adenocarcinoma continue 20 June 2023 ASCO 2023 – Gilead/Arcus’s Tigit data worsen 3 June 2023 Astra’s Flaura2 knocks another hole in Mariposa 17 May 2023 At last, Immutep has some Lag3 data to shout about 17 May 2023 A major setback for Patrick Soon-Shiong 11 May 2023 Load More